Joan Guitart

Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer

Elise A. Olsen, Sean Whittaker, Youn H. Kim et al. · Journal of Clinical Oncology · 2011 · 641 citations · Full text

Immunodeficiencies, Immunology, Clinical End Points +17

Fluorescence In Situ Hybridization (FISH) as an Ancillary Diagnostic Tool in the Diagnosis of Melanoma

Pedram Gerami, Susan Jewell, Larry E. Morrison et al. · The American Journal of Surgical Pathology · 2009 · 465 citations

Engineering, Pathology, Fish Data +18

Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model

Julia Scarisbrick, H. Miles Prince, Maarten H. Vermeer et al. · Journal of Clinical Oncology · 2015 · 407 citations · Full text

The mutational landscape of cutaneous T cell lymphoma and Sézary syndrome

Ana Carolina da Silva Almeida, Francesco Abate, Hossein Khiabanian et al. · Nature Genetics · 2015 · 365 citations · Full text

Sézary Syndrome, Lymphoid Neoplasia, Autoimmune Disease +11

Hand foot skin reaction in cancer patients treated with the multikinase inhibitors sorafenib and sunitinib

Mario E. Lacouture, Laurence Reilly, Pedram Gerami et al. · Annals of Oncology · 2008 · 243 citations · Full text

Medicine, Multikinase Inhibitors, Pathology +8